IVD Technology
May/June 1997
Selected Contents
Editor's Page
Survival in the wild.
Pathogen-free human serum protein production using a hollow-fiber bioreactor system
Artificial production may eliminate the shortages, variability, and possible contamination that complicate use of human serum proteins.
James H. Kelly, Andrea L. Spiering, Norman L. Sussman
Meeting the challenge of stability
Knowing how to define and evaluate the causes of instability is an essential tool for companies seeking to supply more convenient and stable in vitro diagnostic products.
Craig M. Jackson
Industry News
Pall-Gelman merger leads sector consolidation
Physicians turn thumbs down on PSA testing
Commentary
Design control: IVD designers need to fine-tune their systems.
Z. Frank Twardochleb
